Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study.
Ling XuWenxiu PengXiaojing SongYanling LiYang HanTing ZhuQiang FuXiaoli DuWei CaoTai-Sheng LiPublished in: BMC infectious diseases (2021)
NCT04596488 ; Registered 21 October, 2020; Retrospectively registered.